$AMRZ

Forrest Nollaig purchased $100K of AMRZ

Forrest Nollaig (Chief Mktg & Corp Affairs Off) purchased 2,000 shares of Amrize Ltd (AMRZ) at $50.25 ($0.10M total) on 2026-05-22.

Original reporting
SEC EDGAR · Forrest Nollaig
Published May 26, 2026, 5:47 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 5:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMRZ
Bullish
medium confidence
Mentioned
$AMRZ
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMRZBullishMed
01

Why it matters

This disclosure may slightly improve sentiment toward AMRZ, but it does not constitute a fundamental catalyst (no earnings, deal, or regulatory update provided).

02

Market read

Traders may use the insider buy as a minor bullish input, but expect limited price reaction absent additional news.

03

What to watch

Transaction size (~$100.5k) is relatively small; without follow-on buys/sells or guidance, signal strength is likely weak.

Relevance 7/10Timing: Immediate (filed 2026-05-26; trade date 2026-05-22) for short-term sentiment checks.

Background

The filing is an SEC Form 4 insider transaction: Forrest Nollaig (Chief Mktg & Corp Affairs Officer) bought AMRZ shares in an open-market purchase, not under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$AMRZBullishMedium confidence
Context

Amrize Ltd (AMRZ) disclosed an officer open-market purchase of 2,000 shares at $50.25 on 2026-05-22 via SEC Form 4.

Expected impact

Likely limited near-term impact; could add incremental support if market treats it as confidence signal.

Evidence & confidence

Form 4 shows direct officer buying and no 10b5-1 plan, yet the article provides no operational catalyst or size context beyond ~$100.5k.

Market effects

Minimal—this is company-specific insider activity with no stated sector-wide catalyst.

None indicated; no geographic or cross-border developments mentioned.

None indicated; transaction is a routine SEC insider disclosure.

Counterpoint

Insider buys can be routine liquidity/compensation-related actions and may not reflect new fundamentals, especially without additional corroborating news.

Key entities

  • Amrize Ltd

    AMRZ insider disclosed an open-market purchase of 2,000 shares at $50.25 on 2026-05-22.

  • Forrest Nollaig

    Chief Mktg & Corp Affairs Officer; purchased 2,000 AMRZ shares directly.

Related articles

MedAI 8/10

Why is Amrize stock sliding today?

Amrize AG shares fell about 9.1% to around 38 after the company reported Q2 2026 results. EPS was $0.88 vs $0.96 expected, while revenue was $3.5B vs $3.35B expected. Amrize cut full-year adjusted EBITDA guidance, citing higher costs linked to elevated oil prices, driving the selloff.

$AMRZMedAI 8/10

Why is Amrize stock falling today?

Amrize AG shares fell 9.1% to CHF 38.02 after Q2 results missed expectations and the company cut its full-year adjusted EBITDA outlook, citing oil-price driven cost inflation. Q2 EPS was $0.88 vs $0.96 expected, while organic revenue rose 6.7% to $3.5B. Full-year revenue guidance was raised to $12.5B-$12.7B, but adjusted EBITDA was lowered to $3.1B-$3.2B.

$AMRZHighAI 9/10

Amrize Reports Second Quarter 2026 Results

Amrize (AMRZ) reported Q2 2026 revenues of $3,494 million, up 8.6% year over year, with net income rising 14.4% to $476 million and adjusted EBITDA up 5.8% to $986 million. The company returned $502 million via buybacks and dividends and raised FY 2026 guidance, citing demand and oil-price driven cost inflation. Capex was $241 million in the quarter.

$AMRZHigh

Amrize Ltd (AMRZ): Results of Operations and Financial Condition

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 amrizeq22026pressrelease.htm EX-99.1 amrizeq22026pressrelease Amrize Reports Second Quarter 2026 Results • Revenues up 8.6% with organic growth of 6.7% on strong demand and pricing • Net Income increased 14.4% to $476 million and Adjusted EBITDA grew 5.8% to $986 millio